Cardiovascular risks post-COVID-19 vaccination: Key findings

Less than half of patients who were positive for high-risk human papillomavirus (HPV) with negative cytologic findings were retested during the guideline-recommended time frame, a

RP-3 is under clinical development by Replimune and currently in Phase I for Lung Cancer.

“Pirates” who set up scam websites pretending to be various medical and professional societies pop up every year to intercept unsuspecting attendees of annual meetings